Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Nonlymphoblastic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02152956
What this trial is testing

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Who this might be right for
AML
MacroGenics 244
Testing effectiveness (Phase 2)Study completedNCT00003875
What this trial is testing

Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+5 more
Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT01475370
What this trial is testing

Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)

Who this might be right for
Acute Myeloid Leukemia
Otsuka Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Study completedNCT00136422
What this trial is testing

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplasia
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT02763475
What this trial is testing

NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents

Who this might be right for
Acute Myeloid LeukemiaLeukemiaMyeloid Leukemia
Instituto de Investigación Hospital Universitario La Paz 7
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT07668557
What this trial is testing

Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
iCell Gene Therapeutics 18
Early research (Phase 1)Looking for participantsNCT06313437
What this trial is testing

Revumenib in Combination With 7+3 + Midostaurin in AML

Who this might be right for
Acute Myeloid LeukemiaAML, AdultAML With Gene Mutations+2 more
Richard Stone, MD 22
Testing effectiveness (Phase 2)Study completedNCT01101880
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
University of Washington 50
Early research (Phase 1)Study completedNCT05548088
What this trial is testing

LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia and Chronic Granulocytic-Mononocytic Leukemia
Peking University People's Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT03709576
What this trial is testing

Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Milton S. Hershey Medical Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00522990
What this trial is testing

Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Astex Pharmaceuticals, Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT04639024
What this trial is testing

ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Myeloproliferative Neoplasm (MDS/MPN)
Gwynn Long, M.D. 3
Testing effectiveness (Phase 2)Study completedNCT00687323
What this trial is testing

Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic Syndrome
Merck Sharp & Dohme LLC 47
Testing effectiveness (Phase 2)UnknownNCT04353479
What this trial is testing

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 29
Testing effectiveness (Phase 2)Looking for participantsNCT06138990
What this trial is testing

Pharmacoscopy-guided Clinical Standard-of-care in r/r AML

Who this might be right for
AML, Adult
ETH Zurich 88
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Early research (Phase 1)Looking for participantsNCT06737523
What this trial is testing

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapseRefractory AML
The First Affiliated Hospital of Xiamen University 30
Very early researchUnknownNCT03795779
What this trial is testing

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Not applicableStudy completedNCT04326023
What this trial is testing

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)

Who this might be right for
Cancer
University Hospital, Caen 178
Next Page